Xilio Therapeutics, INC. (XLO) — SC 13G/A Filings

All SC 13G/A filings from Xilio Therapeutics, INC.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.

SC 13G/A Filings (8)

SC 13G/A Filing — Nov 14, 2024
SC 13G/A Filing — Nov 14, 2024
SC 13G/A Filing — Nov 12, 2024
SC 13G/A Filing — Nov 12, 2024
SC 13G/A Filing — Jul 31, 2024
SC 13G/A Filing — Apr 5, 2024
Octagon Capital Advisors Exits Xilio Therapeutics Stake — Feb 6, 2024
Octagon Capital Advisors LP, a Delaware-based investment firm, filed an Amendment No. 2 to its Schedule 13G on February 6, 2024, indicating a significant change
Octagon Capital Advisors LP Holds 1.785M Shares of Xilio Therapeutics — Feb 5, 2024
Octagon Capital Advisors LP, a Delaware-based investment firm, filed an amended Schedule 13G/A on February 5, 2024, disclosing its beneficial ownership in Xilio

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX